TrialBMC cancer2025

The MyCancerGene study: a hybrid type 1 effectiveness-implementation randomized study comparing a patient-centered digital genetic health portal to usual care after receipt of cancer genetic testing.

Daniel Chavez-Yenter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.